Showing results (51-60 of 1,751) with videos related to

Sort By:
Pageof 176
Asian Pacific Journal of Allergy and Immunology|December 1, 1985
Effects of azelastine on allergen- and exercise-induced asthmaS Motojima, Y Ohashi, T Otsuka, et al.
International Archives of Allergy and Immunology|November 18, 1997
Serum levels of eosinophil cationic protein and IL-5 in patients with asthma without systemic corticosteroidsS Motojima, K Tateishi, T Koseki, et al.
International Archives of Allergy and Immunology|November 18, 1997
Production of IL-8 and release of eosinophil-derived neurotoxin by normal peripheral blood eosinophilsH Nakajima, G J Gleich, T Fukuda, et al.
Arerugi = [Allergy]|March 1, 1989
[Three cases of food-dependent exercise-induced anaphylaxis]I Akutsu, S Motojima, Y Ikeda, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 1, 1996
Detection of transforming growth factor-beta in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assayT Adachi, S Motojima, A Hirata, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|December 1, 1993
[Detection of IL-5 mRNA in bronchial biopsies from asthmatics by non-radioactive in situ hybridization]T Numao, T Fukuda, I Akutsu, et al.
Arerugi = [Allergy]|April 1, 1990
[Relationship between presence of Creola bodies and airway hyperresponsiveness in patients with bronchial asthma]S Motojima, A Kushima, H Ogata, et al.
Arerugi = [Allergy]|October 1, 1991
[Eosinophil activation in acute asthma attacks evaluated by electronmicroscopic findings of eosinophils and the concentration of eosinophil cationic protein in sputum]Y Oohashi, S Motojima, A Kushima, et al.
The Journal of Allergy and Clinical Immunology|December 1, 1996
Eosinophil peroxidase stimulates the release of granulocyte-macrophage colony-stimulating factor from bronchial epithelial cellsS Motojima, T Adachi, K Manaka, et al.
Arzneimittel-Forschung|September 1, 1995
Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochlorideT Fukuda, T Numao, I Akutsu, et al.
Pageof 176